This drug is not covered on the Reformulary.
There are other clinically similar drugs that are more cost-effective and coordinate well with provincial drug programs. Other therapies, available through Special Authorization, include biosimilars as well as other biologics or JAK inhibitors.
ENTYVIO is used to treat
Inflammatory Bowel Disease (IBD)